KINIKSA ANNOUNCES FDA APPROVAL OF ARCALYST ® (RILONACEPT) FOR RECURRENT PERICARDITIS
PHASE 3 TRIAL OF INTERLEUKIN-1 TRAP RILONACEPT IN RECURRENT PERICARDITIS
RILONACEPT PREVENTS RECURRENT PERICARDITIS: RHAPSODY
IMAGING-GUIDED THERAPIES FOR PERICARDIAL DISEASES
IRAP STUDY
MANAGEMENT OF ACUTE AND RECURRENT PERICARDITIS
THE USE OF COLCHICINE IN PERICARDIAL DISEASES
EXERCISE IS GOOD FOR THE HEART BUT NOT FOR THE INFLAMED PERICARDIUM?
